Introduction
There have been several reports of altered vitamin D metabolism and osteomalacia in epileptics treated with anticonvulsants, including phenobarbital (Dent et al., 1970; Hahn et al., 1972; Kruse, 1968; Richens and Rowe, 1970) . These drugs appear to influence vitamin D metabolism by inducing hepatic microsomal enzymes (Dent et al., 1970; Richens and Rowe, 1970) . Use of barbiturates was recently implicated in the osteodystrophy complicating long-term haemodialysis and renal transplantation (Pierides et al., 1976) . One of the authors (L.E.R.) had formed a clinical impression that low serum calcium and elevated alkaline phosphatase values were unduly frequent in elderly patients receiving barbiturates, often at ordinary hypnotic doses. Others had suggested that the combination of nutritional deficiency of vitamin D and barbiturate habituation may cause more morbidity in the elderly than is generally recognized (Fraser, Thompson and Khan, 1976) .
For these reasons the authors undertook the retrospective study described below, seeking evidence that barbiturate treatment in the elderly for indications other than epilepsy may adversely affect vitamin D metabolism.
Methods

Population studied
The basis for the study was a laboratory screening (Whitefield et al., 1973) . Substitution of these drugs allows healing of drug-induced osteomalacia (Greenwood, Prunty and Silver, 1973) . Of thirty-nine subjects, twelve were receiving nitrazepam, twenty-five diazepam, and two both drugs. (Hunter, 1974 (Dent et al., 1970; Hahn et al., 1972; Kruse, 1968; Pierides et al., 1976; Richens and Rowe, 1970) , it seems reasonable to suggest that barbiturates were responsible for the reduction in serum calcium.
The clinical significance of the reduced serum calcium cannot be assessed from the present study and, in particular, the authors do not know whether it means that a number of these patients had osteomalacia. In the original survey the decision whether to investigate any biochemical abnormality was left to the individual doctors in the practice. As a result of the survey one of twenty-four patients receiving barbiturates was found to have radiological osteomalacia (presumed nutritional), while three of 378 subjects not receiving bariburates had osteomalacia diagnosed. Although the numbers are too small to be significant it is notable that the barbiturate patient in whom osteomalacia was diagnosed had a corrected serum calcium of 2-23 mmol/l, while fourteen subjects in the barbiturate group had values lower than this. Since hypocalcaemia may be the only biochemical abnormality in osteomalacia (Stanbury, 1972) it is quite possible that further cases went undiagnosed in the barbiturate group. On the other hand the reduction in serum calcium may be a trivial biochemical abnormality, and further study will be required to determine its significance.
Comparing these findings with those in epileptics treated with anticonvulsants (Richens and Rowe, 1970) the reduction in serum calcium in the barbiturate group was of the same magnitude as that observed with anticonvulsants, and serum phosphate was unaltered in both studies. However, the results for serum alkaline phosphatase differed in the two studies. Epileptics treated with anticonvulsants had alkaline phosphatase values significantly higher than a control group, a difference not observed with barbiturates in the present study. The prevalence of elevated alkaline phosphatase levels using the same criteria was identical in patients treated with anticonvulsants and in those treated with barbiturates in the present study, but the findings in the control groups show that the criteria are too strict in the age range studied. In epileptics, elevated alkaline phosphatase was most frequently due to an increase in the liver isoenzyme, the bone fraction rising particularly in young patients aged [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] years (Richens and Rowe, 1970) . The authors speculate that higher doses of barbiturate or combination with other anticonvulsants may be required to elevate the alkaline phosphatase, or that the alkaline phosphatase response may be modified in older patients.
Although the authors do not know the dose and duration of barbiturate treatment in their subjects, the drugs were not being prescribed as anticonvulsants, and in thirteen of the twenty-one subjects, the barbiturate was used as a hypnotic. It is probable that the reduction in serum calcium was associated with use of barbiturate at low or moderate dosage.
The mechanism for altered vitamin D metabolism due to anticonvulsant drugs is not entirely clear (Christiansen et al., 1975; Stanbury, 1972) but it seems related to induction of hepatic microsomal enzymes (Dent et al., 1970; Richens and Rowe, 1970) . Since it has been shown that barbiturates can cause enzyme induction when given in doses commonly used for hypnotic purposes (Whitefield et al., 1973) , adverse effects of these ordinary doses on vitamin D metabolism would not be surprising, and may not be restricted to the elderly.
It is concluded that barbiturate treatment in the elderly, even at conventional non-anticonvulsant dosage, may influence vitamin D metabolism adversely. Clinicians should be alert to the possibility of osteomalacia in such patients. The conclusion from the present study will require to be tested prospectively and younger age groups should also be examined. The authors believe that their findings provide yet another reason why barbiturates should be reserved for those few indications where their use is essential.
